International Journal of Infectious Diseases (Jun 2019)

First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus

  • Merav Weil,
  • Galia Rahav,
  • Raz Somech,
  • Tali Stauber,
  • Jacqueline Alfandari,
  • Leah Weiss,
  • Ilana Silberstein,
  • Victoria Indenbaum,
  • Itay Bar Or,
  • Ella Mendelson,
  • Danit Sofer,
  • Lester M. Shulman

Journal volume & issue
Vol. 83
pp. 40 – 43

Abstract

Read online

This is the first report of persistent oropharyngeal mucosal infection with type 2 poliovirus (iVDPV2) in a primary immune deficient patient (PID) after wild type 2 poliovirus eradication. The iVDPV2 also established persistence in the gut. iVDPV2 at both loci evolved independently. Persistent oral infections present a potential risk for oral-oral as well as fecal-oral poliovirus transmission during transition to a poliovirus 2-free world. Keywords: Primary immune deficiency (PID), Type 2 vaccine-derived poliovirus (iVDPV2), Stools, Oropharyngeal mucosa, Contact isolation, Droplet isolation